Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The viral RNA replication and translation machinery is a multi-component assembly of viral proteins and co-opted host factors essential for the life cycle of RNA viruses (Subissi et al., 2014, Nature Reviews Microbiology). At its core is the RNA-dependent RNA polymerase (RdRp), which works in tandem with helicases, exonucleases, and proteases to replicate the viral genome and transcribe messenger RNA (Hillen et al., 2020, Nature). This machinery also facilitates the hijacking of host ribosomes and translation initiation factors to ensure the preferential synthesis of viral proteins over host proteins (Walsh & Mohr, 2011, Nature Reviews Microbiology). Because many components of this machinery, such as the RdRp, have no functional equivalents in human cells, they serve as high-priority targets for broad-spectrum and virus-specific antivirals (Pruijssers & Denison, 2019, Current Opinion in Virology). Drugs like remdesivir and sofosbuvir act as nucleoside analogs that incorporate into the growing RNA strand, causing premature termination of the replication process (Gordon et al., 2020, Nature). However, the high error rate of viral replication often leads to the emergence of resistant mutations, posing a significant challenge for long-term therapeutic efficacy (Agostini et al., 2018, mBio).
Inhibition of RNA-dependent RNA polymerase (RdRp) leading to chain termination or lethal mutagenesis; inhibition of viral proteases to prevent polyprotein cleavage; interference with viral RNA capping and translation initiation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral RNA replication and translation machinery (RTC).